Initial Development of SARS-CoV-2 Antigen Assay Using BAMS Technology and MALDI-TOF

Applications | 2020 | BrukerInstrumentation
MALDI, LC/TOF, LC/MS, LC/MS/MS
Industries
Clinical Research
Manufacturer
Bruker
Downloadable PDF for viewing
 

Similar PDF

Recombinant SARS-CoV-2 Receptor Binding Domain: Comprehensive Top-Down Sequence Confirmation, Curation and O-Glycosylation Site Determination
Next-generation MALDI top-down sequencing of protein biotherapeutics – expanding the scope of timsTOF technology
QUANTITATIVE EVALUATION OF AFFIMER AND MOLECULAR IMPRINTED POLYMER AFFINITY GLYCOPROTEINS ANALYSIS BY MULTIPLE REACTION MONITORING LC-MS/MS
Bruker Product Overview - Life Science Mass Spectrometry
Bruker Product Overview - Life Science Mass Spectrometry
2020|Bruker|Brochures and specifications